CAS: 2272904-53-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Zasocitinib-13C-d3 (TAK-279-13C-d3) REF: 4Z-Z-050002CAS: 2272904-53-5 | - - - | To inquire | Tue 28 Jan 25 |
| Zasocitinib (TAK-279) REF: 4Z-Z-050001CAS: 2272904-53-5 | - - - | To inquire | Tue 28 Jan 25 |
 | NDI-034858 REF: TM-T62902CAS: 2272904-53-5 | 100% | 246.00 €~3,149.00 € | Tue 22 Apr 25 |
Ref: 4Z-Z-050002
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Ref: 4Z-Z-050001
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 Jan 2025
NDI-034858
CAS:2272904-53-5
NDI-034858 (TAK-279) is a tyrosine kinase 2 (TYK2) inhibitor (Kd<200 pM) that targets the …
Formula:
C23H24N8O3
Purity:
100%
Color and Shape:
Liquid
Molecular weight:
460.49
Ref: TM-T62902
| 1mg | 246.00 € | ||
| 5mg | 737.00 € | ||
| 10mg | 1,177.00 € | ||
| 25mg | 1,736.00 € | ||
| 50mg | 2,364.00 € | ||
| 100mg | 3,149.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025
